
Krishna Institute of Medical Sciences Q1 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
Yes
Order
N/A
Capex
Yes
2 of 4 growth signals are positive.
Full analysisRevenue guidance
Category 3- Telangana and Andhra Pradesh clusters continue revenue growth at 15% YoY, with room for new specialty additions (oncology, mother & child care, interventional procedures) to drive further growth.
- Incremental bed additions of ~1500 beds in Andhra and Telangana over 24-36 months, maintaining occupancy around 70-75%.
- Sunshine and Nagpur hospitals expected to scale up with improved occupancy and doctor additions, contributing positively to revenue.
- New facilities in Bangalore (750 beds) to start operations between Q1 and Q2 FY25, with significant capex (~INR 650 crores).
- Thane and Nashik projects progressing with expected capacity additions.
- ARPOB (Average Revenue Per Occupied Bed) expected to grow at a blended 3-5% rate, driven mainly by new clinical therapies and pricing from insurance.
- EBITDA margins anticipated to improve as new facilities mature, with incremental revenue converting 40% directly to EBITDA in key clusters.
See what Krishna Institute of Medical Sciences management said on margin guidance — free account, 30 seconds.
Fundraise plans
Yes- There is no explicit mention of any current or planned fundraising through debt or equity in the transcript.
- Finance cost has doubled this quarter mainly due to drawing down limits for Sunshine units.
- Management stated financing options include using existing limits for capex or drawing from available profits.
- No definitive commitment or plan for fresh debt or equity issuance was shared.
- Expansion projects are primarily funded by internal accruals or existing credit limits.
- The company appears focused on operational growth and capacity ramp-up rather than new external fundraising currently.
See what Krishna Institute of Medical Sciences management said on order book — free account, 30 seconds.
Capex plans
Yes- Capex will start mostly from next fiscal year, with significant investment planned for new hospitals and facility expansions.
- Bangalore: Two hospitals with 750 beds combined, INR 650 crores total outlay (~INR 80 lakhs per bed); one asset 50% owned, other on revenue share model.
- Thane project: INR 400 crores capex, with construction underway and transaction closure with investor expected soon; operational by Q1 or Q2 of next fiscal.
- Nashik hospital projected to be operational by Q4 of current financial year or early Q1 next year.
- Kondapur expansion: Incremental 400 beds planned to begin two years from now.
- Expansion in Andhra with new oncology centers and mother & child care units across multiple facilities.
- Emphasis on ramping up Sunshine and Nagpur hospitals, including shifting OPD/IPD in Sunshine from August.
- Corporate overhead costs currently impacting Telangana cluster margins due to expansion activities.
Track Krishna Institute of Medical Sciences — get its next earnings analysis in your feed
How does Krishna Institute of Medical Sciences rank vs peers in Healthcare Services?
Pro featureHow does Krishna Institute of Medical Sciences rank in Healthcare Services?
Compare Krishna Institute of Medical Sciences against every Healthcare Services company (Q1 FY24) on revenue, margins and earnings-call signals.
Continue your research
What Krishna Institute of Medical Sciences's management said in earlier quarters
Others in Healthcare Services this season
- Chandan Healthca (Q2 FY27)
Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor
- Invicta Diagnostic (Q2 FY27)
Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2
- Unihealth Hosp (Q2 FY27)
1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r
- Sangani Hospital (Q2 FY27)
1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.